KFin Technologies has invested USD 35,000,000 in its Singapore-based subsidiary. This investment will allow the Singapore Subsidiary to acquire a 51% controlling stake in Ascent Fund Services (Singapore) Pte. Ltd. Through the Ascent Fund, the Singapore Subsidiary will focus on delivering global fund administration and other financial technology solutions services. This investment was completed on October 08, 2025.

Investment in Singapore Subsidiary

KFin Technologies announced an investment of USD 35,000,000 in its wholly owned Singapore Subsidiary on October 08, 2025. This move is aimed at expanding the subsidiary’s capabilities and market reach.

Acquisition of Controlling Stake

The capital infusion will enable the Singapore Subsidiary to acquire a 51% controlling stake in Ascent Fund Services (Singapore) Pte. Ltd, referred to as “Ascent Fund”. Through this acquisition, KFin Technologies aims to strengthen its presence in the global fund administration space.

Strategic Objectives

The Singapore Subsidiary, leveraging the Ascent Fund, will focus on offering a range of services, including global fund administration, corporate solutions, and other financial technology solutions to cater to global investment managers.

Source: BSE

Nestlé India has announced the issuance of a compliance certificate pertaining to the handling of securities for the quarter ended September 30, 2025. The certificate confirms adherence to regulatory requirements related to depositories and participants. This announcement highlights Nestlé India’s commitment to maintaining transparency and compliance in its operations.

Certificate of Compliance

Nestlé India has received a certificate regarding the management and handling of securities for Q2 FY26 (quarter ended September 30, 2025). The certificate, issued by Alankit Assignments Limited, confirms compliance with applicable regulations concerning depositories and participants.

Details of Confirmation

The certificate confirms that the securities mentioned have been listed on the stock exchanges. Furthermore, it verifies that physical share certificates received for dematerialization have been duly processed: after proper verification, they have been mutilated, cancelled, and the depository has been listed as the registered owner in company records.

The Company has confirmed this information for both the National Securities Depository Limited and the Central Depository Services (India) Limited.

Source: BSE

Vardhman Textiles has received a certificate concerning the dematerialization of securities for the quarter ending September 30, 2025. The certificate confirms compliance with SEBI regulations regarding the handling of physical share certificates received for dematerialization. All relevant share certificates have been duly verified, mutilated, and cancelled, with the depository’s name substituted in the company’s records.

Certificate of Compliance

Vardhman Textiles Limited confirms that it has received the necessary certification regarding the dematerialization of the company’s securities. This certificate covers all transactions for the quarter ending September 30, 2025.

Details of Dematerialization

The certificate, provided by Alankit Assignments Limited, the Registrar and Share Transfer Agent, confirms that all physical share certificates submitted for dematerialization have been properly handled in accordance with established regulatory guidelines. All certificates received have undergone due verification processes.

Specifically, the certificates confirm the following:

• The securities listed are compliant with Stock Exchange requirements.
• All share certificates have been mutilated and canceled after verification.
• The depository’s name has been accurately recorded in place of the original owner.

Source: BSE

Manyavar has announced the issuance of a compliance certificate pertaining to Regulation 74(5) for the quarter ended September 30, 2025. The certificate, received from KFin Technologies Limited, confirms compliance with depositories and participants regulations. This announcement ensures stakeholders are informed of Manyavar’s adherence to regulatory requirements and transparency in its operations.

Compliance Certificate Received

Manyavar has received a certificate under Regulation 74(5) for the quarter ended September 30, 2025. The certificate was issued by KFin Technologies Limited, the Registrar and Share Transfer Agent (RTA) for Vedant Fashions Limited.

Details of the Certificate

The certificate confirms that the details of securities dematerialized/rematerialized during the quarter have been duly furnished to all stock exchanges, as required. This ensures compliance with the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

Confirmation of Information

The company has requested the stock exchanges to take the information on record, ensuring transparency and adherence to regulatory norms. The announcement was made on October 08, 2025.

Source: BSE

Vardhman Textiles Limited announced the dematerialization of 3,865 equity shares in September 2025. This includes 3,665 shares dematerialized through CDSL and 200 shares through NSDL. The company has duly verified the share certificates, and after the dematerialization, the certificates have been cancelled and replaced with the name of the Depository as the Registered Owner.

Share Dematerialization Details

Vardhman Textiles Limited has completed the dematerialization of equity shares for the month of September 2025. A total of 3,865 equity shares were dematerialized after verifying the respective share certificates.

Dematerialization Breakdown

The dematerialization was carried out through two depositories:

• CDSL (Central Depository Services Limited): 3,665 shares were dematerialized.
• NSDL (National Securities Depository Limited): 200 shares were dematerialized.

CDSL Dematerialization Details

The following table summarizes the dematerialization of shares through CDSL:

001504676 to 001505875 using certificate number 00001848: 1575 shares (22/09/2025)
000080006 to 000080380 using certificate number 00000155:
001527451 to 001528940 using certificate number 00001892: 1490 shares (23/09/2025)
001452321 to 001452920 using certificate number 00001723: 600 shares (30/09/2025)

NSDL Dematerialization Details

The following table summarizes the dematerialization of shares through NSDL:

002230121 to 002230255 using certificate number 00002556: 135 shares (25/09/2025)
002098841 to 002098905 using certificate number 00002435: 65 shares (30/09/2025)

Post-Dematerialization Update

Upon completion of the dematerialization process, the physical share certificates were cancelled and replaced with the name of the Depository as the Registered Owner in the company’s records.

Source: BSE

Sai Life Sciences has partnered with Agility Life Sciences and Centrix Pharma Solutions to launch an Integrated CMC Partnership. This collaboration aims to accelerate drug development for innovator biopharma companies by providing end-to-end services from API development to clinical manufacturing. The partnership combines the strengths of all three organizations, offering integrated drug substance and drug product development to improve efficiency from preclinical studies to clinical trials.

Strategic Collaboration for Drug Development

Sai Life Sciences, Agility Life Sciences, and Centrix Pharma Solutions have announced the launch of an Integrated CMC Partnership, designed to expedite drug development for innovator biopharma companies. This collaboration integrates the strengths of each company to provide comprehensive Chemistry, Manufacturing, and Controls (CMC) services.

Comprehensive End-to-End Services

The partnership aims to offer end-to-end services, from API development to clinical manufacturing. This includes integrated drug substance and drug product development, helping clients move efficiently from preclinical studies to first-in-human (FIH) clinical trials and beyond. Key benefits of the partnership include:

• Broad scientific expertise across multiple disciplines.
• End-to-end service coverage from synthetic route scouting to drug substance manufacturing.
• Cross-functional optimization: integrated planning across API and drug product development.
• Agility and flexibility to proactively respond to emerging technical risks.
• Seamless coordination between technical teams.
• Single point of contact from Day One.

Quotes from Leadership

Krishna Kanumuri, MD & CEO, Sai Life Sciences, stated, “We are delighted to partner with Agility Life Sciences and Centrix Pharma in this truly integrated CMC offering… By bringing together our complementary strengths, we can deliver far greater value to innovators.”

Dr Claire Thompson, CEO and Founder, Agility Life Sciences, commented, “Our combined expertise and energy will enable our clients’ molecules to be accelerated through key milestones, while reducing risk and cost.”

Chris Davison, CEO, Centrix Pharma Solutions, added, “What excites me most about this partnership is the spirit of collaboration it represents… At its heart, this is about people working side by side to turn promising science into medicines that can change lives.”

Source: BSE

United Spirits Limited has appointed Mr. Narayan K Seshadri as an Additional Director (Non-Executive, Independent Director) effective October 9, 2025. The appointment was approved by the Board of Directors based on the recommendation of the Nomination and Remuneration Committee. Mr. Seshadri’s term is subject to shareholder approval and will be for a period of three years.

Leadership Change

United Spirits Limited has announced the appointment of Mr. Narayan K Seshadri (DIN: 00053563) as an Additional Director, categorized as Non-Executive and Independent. This key decision was finalized during a board meeting held on October 8, 2025.

Appointment Details

The appointment of Mr. Seshadri is effective from October 9, 2025, and his tenure will last for three years. The appointment remains subject to the approval of the company’s shareholders.

About Narayan K. Seshadri

Mr. Narayan K Seshadri brings over 42 years of corporate experience to United Spirits. A qualified Chartered Accountant, he previously held the position of Managing Partner at KPMG’s business advisory practice in India. His experience also includes being a member of Andersen’s Global CEO Advisory Council. He has worked with Fortune 500/FTSE 100 companies, as well as start-ups across international markets.

Mr. Seshadri also serves as a board member of Tranzmute Capital & Management Pvt. Ltd. In the past, he was among the early finance professionals to invest in and revive troubled companies.

Source: BSE

InterGlobe Aviation confirms compliance with SEBI regulations for the quarter ended September 30, 2025. A certificate from KFin Technologies Limited, the Registrar and Share Transfer Agent, verifies that all company securities are held in dematerialized form. There were no requests for rematerialization during this period, thus the mentioned regulations are not applicable to the company for this quarter.

Compliance Certificate Received

InterGlobe Aviation has received a certificate from KFin Technologies Limited confirming compliance with specific SEBI regulations for the quarter that concluded on September 30, 2025.

Details of Compliance

The certificate confirms that all securities of InterGlobe Aviation are held in dematerialized form. Furthermore, no requests for rematerialization of securities were received during Q2 FY26.

Impact and Applicability

As all securities are held in dematerialized form and no rematerialization requests were made, the company states that the stipulations of certain SEBI regulations are not applicable to InterGlobe Aviation for the period ending September 30, 2025.

Source: BSE